801 Risk-benefit ratio in immunotherapy (IO) with or without chemotherapy (CT) according to PD-L1 expression: a model-based approach to inform treatment decisions in metastatic non-small cell lung cancer
Journal for ImmunoTherapy of Cancer（2023）
关键词
lung cancer,immunotherapy,chemotherapy,risk-benefit,model-based,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要